NLRP3 and liver disorder: This hepatoprotective effect of MOE could be attributed to the presence of quercetin (Table 3) as a protective agent for liver diseases, as quercetin inhibited liver inflammation primarily via NF-B/TLR/NLRP3, mTOR activation in autophagy, and inhibited the expression of apoptotic factors associated with the development of liver diseases as recorded by Zhao et al. (2021).